Studies

Showing 124 studies.

P1113: AERAS-404 TB Vaccine in BCG-Primed Infants

DAIDS Number

Research Area

Study Status

Closed to Follow Up

P1112: Monoclonal Antibody PK Study

DAIDS Number

Research Area

Study Status

Closed to Follow Up

P1110: Safety and PK of RAL in Neonates

DAIDS Number

Research Area

Study Status

P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV

DAIDS Number

Research Area

P1107: Cord Blood Transplantation

DAIDS Number

Research Area

Study Status

Closed to Accrual

P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants

DAIDS Number

Research Area

Study Status

Closed to Follow Up

P1104s: Longitudinal Developmental and Neuropsychological Assessments of HIV-Infected Participants of P1060 and HIV-Uninfected Controls

DAIDS Number

Research Area

Complications & Comorbidities

Study Status

Participants Off Study and Primary Analysis Completed

P1101: Phase I/II Dose-Finding, Safety, Tolerance and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-infected and TB Co-infected Infants and Children

DAIDS Number

Research Area

Study Status

P1100: AERAS 402

DAIDS Number

Research Area

Study Status

P1097: Raltegravir PK Study

DAIDS Number

Research Area

Study Status